Skip to main content

Tumor Infiltration by Monocytes and the Antitumor Effects of Monocyte Chemoattractant Protein-1

  • Chapter
Chemokines and Cancer

Part of the book series: Contemporary Cancer Research ((CCR))

Abstract

Mononuclear cell infiltration is a common feature of many types of human cancers. In fact, its occurrence is considered so unremarkable that there are no systematic studies describing the prevalence or intensity of infiltrates by tumor type or stage. Instead, it is generally asserted that intense infiltrates are associated with certain tumor types, such as medullary carcinoma of the breast and malignant melanoma (1,2), and that most other cancers are also infiltrated to differing extents. Even without an “epidemiology” of tumor-related inflammatory infiltrates, tumor biologists have extensively focused on this phenomenon for more than 100 yr.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Underwood, J. C. E. 1974. Lymphoreticular infiltration in human tumors: prognostic and biological implications: a review. Br. J. Cancer 30: 538–548.

    Article  PubMed  CAS  Google Scholar 

  2. Underwood, J. C. E., and I. Cam 1972. The ultrastructure of the lymphoreticular cells in non-lymphoid human neoplasms. Virchows Arch. Abt. B Zellpath. 12: 39–50.

    CAS  Google Scholar 

  3. Virchow, R. 1863. Die krankhaften Geschwulste. Dreißig Vorlesungen, gehalten während des Wintersemesters 1872–1863 an der Universität zu Berlin. Vorlesungen uber Pathologie, Verlag von August Hirschwald, Berlin.

    Google Scholar 

  4. Waldeyer, H. W. G. 1872. Die entwicklung der carcinome. Virchows Arch. Path. Anat. 55–67.

    Google Scholar 

  5. Jensen, C. O. 1903. Experimentelle untersuchungen über krebs bei mäusen. Zentralbl. f Bakt. Parasit. Infekt. I Abt. Originale. 34: 122–143.

    Google Scholar 

  6. Bashford, E. F. 1905. The growth of cancer under natural and experimental conditions. In: E. F. Bashford, J. A. Murray, and W. Cramer (eds.), Scientific Reports on the Investigations of the ICRF, No. 2 part II. Imperial Cancer Research Fund, London.

    Google Scholar 

  7. Russell, B. R. G. 1908. The nature of resistance to the inoculation of cancer. Third Sci. Rep. ICRF 3: 341–358.

    Google Scholar 

  8. Da Fano, C. 1911. A cytological analysis of the reaction in animals resistant to implanted carcinomata. Fifth Sci. Rep. ICRF 5: 57–75.

    Google Scholar 

  9. Monis, B., and Weinberg, T. 1960. Cytochemical study of esterase activity of human neoplasms and stromal macrophages. Cancer 14: 369–377.

    Article  Google Scholar 

  10. Wade, H. 1980. An experimental investigation of infective sarcoma of the dog, with a consideration of its relationship to cancer. J. Pathol. Bacteriol. 12: 384–425.

    Article  Google Scholar 

  11. Ehrlich, P. 1907. Experimentelle studien an mäustumoren. Zeitschr. f Krebsforschung 5: 59–81.

    Article  Google Scholar 

  12. Burg, G., and Braun-Falco, O. 1972. The cellular stromal reaction in malignant melanoma: a cytochemical investigation. Arch. Derm. Forsch. 245: 318–333.

    CAS  Google Scholar 

  13. Carr, I., and J. C. E. Underwood. 1974. The ultrastructure of the local cellular reaction to neoplasia. Int. Rev. Cytol. 37: 329–347.

    Article  PubMed  CAS  Google Scholar 

  14. Göttlinger, H. G., P. Rieber, J. M. Gokel, K. J. Lohe, and G. Riethmüller. 1985. Infiltrating mononuclear cells in human breast carcinoma: predominance of T4+ monocytic cells in the tumor stroma. Int. J. Cancer 35: 199–205.

    Article  PubMed  Google Scholar 

  15. van Ravenswaay Claasen, H. H., P. M. Kluin, and G. J. Fleuren. 1992. Tumor infiltrating cells in human cancer: on the possible role of CD16+ macrophages in antitumor cytotoxicity. Lab. Invest. 67: 166–174.

    PubMed  CAS  Google Scholar 

  16. Evans, R. 1972. Macrophages in syngeneic animal tumors. Transplantation 14: 468–473.

    Article  PubMed  CAS  Google Scholar 

  17. Cohen, P. J., M. T. Lotze, J. R. Roberts, S. A. Rosenberg, and E. S. Jaffe. 1987. The immunopathology of sequential tumor biopsies in patients treated with interleukin-2: correlation of response with T-cell infiltration and HLA-DR expression. Am. J. Pathol. 129: 208–216.

    PubMed  CAS  Google Scholar 

  18. Gauci, C. L., and P. Alexander. 1975. The macrophage content of some human tumors. Cancer Lett. 1: 29–32.

    Article  PubMed  CAS  Google Scholar 

  19. Eccles, S. A., and P. Alexander. 1974. Macrophage content of tumors in relation to metastatic spread and host immune reaction. Nature 250: 667 - 669.

    Article  PubMed  CAS  Google Scholar 

  20. Berg, J. W. 1959. Inflammation and prognosis in breast cancer: a search for host resistance. Cancer 12: 714–720.

    Article  PubMed  CAS  Google Scholar 

  21. Black, M. M., S. R. Opler, and F. D. Speer. 1955. Survival in breast cancer cases in relation to the structure of the primary tumor and regional lymph nodes. Surg. Gynecol. Obstet. 100: 543–551.

    PubMed  CAS  Google Scholar 

  22. Champion, H. R., I. W. J. Wallace, and R. J. Prescott. 1972. Histology in breast cancer diagnosis. Br. J. Cancer 26: 129–138.

    Article  PubMed  CAS  Google Scholar 

  23. Takahashi, K. 1961. Squamous cell carcinoma of the esophagus: stromal inflammatory cell infiltration as a prognostic factor. Cancer 14: 921–933.

    Article  PubMed  CAS  Google Scholar 

  24. Lauder, I., and W. Aherne. 1972. The significance of lymphocytic infiltrate in neuroblastoma. Br. J. Cancer 26: 321–330.

    Article  PubMed  CAS  Google Scholar 

  25. Barber, H. R. K., S. C. Sommers, R. Snyder, and T. H. Kwon. 1975. Histologic and nuclear grading and stromal reactions as indices for prognosis in ovarian cancer. Am. J. Obstet. Gynecol. 121: 795–807.

    PubMed  CAS  Google Scholar 

  26. Fidler, I. J. 1974 Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages. Cancer Res. 34: 1074–1078.

    PubMed  CAS  Google Scholar 

  27. Dullens, H. F. J., and W. Den Otter. 1974. Therapy with allogeneic immune peritoneal cells. Cancer Res. 34: 1726–1730.

    PubMed  CAS  Google Scholar 

  28. Keller, R. 1976. Promotion of tumor growth in vivo by antimacrophage agents. J. Natl. Cancer Inst. 57: 1355–1361.

    PubMed  CAS  Google Scholar 

  29. Prehn, R. T. 1972. The immune reaction as a stimulator of tumor growth. Science 176: 170, 171.

    Google Scholar 

  30. Mantovani, A., B. Bottazzi, F. Colotta, S. Sozzani, and L. Ruco. 1992. The origin and function of tumor-associated macrophages. Immunol. Today 13: 265–270.

    Article  PubMed  CAS  Google Scholar 

  31. Carrel, A. 1922. Growth-promoting function of leukocytes. J. Exp. Med. 36: 385–391.

    Article  PubMed  CAS  Google Scholar 

  32. Leek, R. D., C. E. Lewis, R. Whitehouse, M. Greenall, J. Clarke, and A. L. Harris. 1996. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res. 56: 4625–4629.

    PubMed  CAS  Google Scholar 

  33. Bottazzi, B., N. Polentarutti, R. Acero, A. Balsari, D. Boraschi, P. Ghezzi, M. Salmona, and A. Mantovani. 1983. Regulation of the macrophage content of neoplasms by chemoattractants. Science 220: 210–212.

    Article  PubMed  CAS  Google Scholar 

  34. Bottazzi, B., P. Ghezzi, G. Tarboletti, M. Salmona, N. Colombo, C. Bonazzi, C. Mangioni, and A. Mantovani. 1985. Tumor-derived chemotactic factor(s) from human ovarian carcinoma: evidence for a role in the regulation of macrophage content of neoplastic tissues. Int. J. Cancer 36: 167–173.

    Article  PubMed  CAS  Google Scholar 

  35. Valente, A. J., D. T. Graves, C. E. Vialle-Valentin, R. Delgado, and C. J. Schwartz. 1988. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture. Biochemistry 27: 4162–4168.

    Article  PubMed  CAS  Google Scholar 

  36. Yoshimura, T., E. A. Robinson, S. Tanaka, E. Appella, J. I. Kuratsu, and E. J. Leonard. 1989. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 169: 1449–1459.

    Article  PubMed  CAS  Google Scholar 

  37. Matsushima, K., C. G. Larsen, G. C. DuBois, and J. J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169: 1485–1490.

    Article  PubMed  CAS  Google Scholar 

  38. Bottazzi, B., F. Colotta, A. Sica, N. Nobili, and A. Mantovani. 1990. A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF). Int. J. Cancer 45: 795–797.

    Article  PubMed  CAS  Google Scholar 

  39. Graves, D. T., Y. L. Jiang, M. J. Williamson, and A. J. Valente. 1989. Identification of monocyte chemotactic activity produced by malignant cells. Science 245: 1490–1493.

    Article  PubMed  CAS  Google Scholar 

  40. Cochran, B. H., A. C. Reffel, and C. D. Stiles. 1983. Molecular cloning of gene sequences regulated by platelet-derived growth factor. Cell 33: 939–947.

    Article  PubMed  CAS  Google Scholar 

  41. Rollins, B. J., E. D. Morrison, and C. D. Stiles. 1988. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc. Natl. Acad. Sci. USA 85: 3738–3742.

    Article  PubMed  CAS  Google Scholar 

  42. Rollins, B. J., P. Stier, T. E. Ernst, and G. G. Wong. 1989. The human homologue of the JE gene encodes a monocyte secretory protein. Mol. Cell. Biol. 9: 4687–4695.

    PubMed  CAS  Google Scholar 

  43. Ernst, C. A., Y. J. Zhang, P. R. Hancock, B. J. Rutledge, C. L. Corless, and B. J. Rollins. 1994. Biochemical and biological characterization of murine MCP-1: identification of two functional domains. J. Immunol. 152: 3541–3549.

    PubMed  CAS  Google Scholar 

  44. Mazzucchelli, L., P. Loetscher, A. Kappeler, M. Uguccioni, M. Baggiolini, J. A. Laissue, and C. Mueller. 1996. Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasie and prostate adenocarcinoma. Am. J. Pathol. 149 (2): 501–509.

    PubMed  CAS  Google Scholar 

  45. Zachariae, C. O. C., A. O. Anderson, H. L. Thompson, E. Appella, A. Mantovani, J. J. Oppenheim, and K. Matsushima. 1990. Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line. J. Exp. Med. 171: 2177–2182.

    Article  PubMed  CAS  Google Scholar 

  46. Rutledge, B. J., H. Rayburn, R. Rosenberg, R. J. North, R. P. Gladue, C. L. Corless, and B. J. Rollins. 1995. High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J. Immunol. 155: 4838–4843.

    PubMed  CAS  Google Scholar 

  47. Simonet, W. S., T. M. Hughes, H. Q. Nguyen, L. D. Trebasky, D. M. Danilenko, and E. S. Medlock. 1994. Long-term impairment of neutrophil migration in mice overexpressing human interleukin-8. J. Clin. Invest. 94: 1310–1319.

    Article  PubMed  CAS  Google Scholar 

  48. Hechtman, D. H., M. I. Cybulsky, H. J. Fuchs, J. B. Baker, and M. A. Gimbrone. 1991. Intravascular IL-8. inhibitor of polymorphonuclear leukocyte accumulation at sites of acute inflammation. J. Immunol. 147: 883–892.

    PubMed  CAS  Google Scholar 

  49. Ley, K., J. B. Baker, M. I. Cybulsky, M. A. Gimbrone, and F. W. Luscinskas. 1993. Intravenous interleukin-8 inhibits granulocyte emigration from rabbit mesenteric vessels without altering L-selectin expression or leukocyte rolling. J. Immunol. 151: 6347–6357.

    PubMed  CAS  Google Scholar 

  50. Karpus, W. J., N. W. Lukacs, K. J. Kennedy, W. S. Smith, S. D. Hurst, and T. A. Barrett. 1997. Differential CC chemokine-induced enhancement of T helper cell cytokine production. J. Immunol. 158: 4129–4136.

    PubMed  CAS  Google Scholar 

  51. Chensue, S. W., K. S. Warmington, J. H. Ruth, P. S. Sanghi, P. Lincoln, and S. L. Kunkel. 1996. Role of monocyte chemoattractant protein-1 (MCP-1) in Thl (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. J. Immunol. 157: 4602–4608.

    PubMed  CAS  Google Scholar 

  52. Fuentes, M. E., S. K. Durham, M. R. Swerdel, A. C. Lewin, D. S. Barton, J. R. Megill, R. Bravo, and S. A. Lira. 1995. Controlled recruitment of monocytes/macrophages to specific organs through transgenic expression of MCP-1. J. Immunol. 155: 5769–5776.

    PubMed  CAS  Google Scholar 

  53. Gunn, M. D., N. A. Nelken, X. Liao, and L. T. Williams. 1997. Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation. J. Immunol. 158: 376–383.

    PubMed  CAS  Google Scholar 

  54. Nakamura, K., I. R. Williams, and T. S. Kupper. 1995. Keratinocyte-derived monocyte chemoattractant protein 1 (MCP-1): analysis in a transgenic model demonstrates MCP-1 can recruit dendritic and Langerhans cells to skin. J. Invest. Dermatol. 105: 635–643.

    Google Scholar 

  55. Sozzani, S., F. Sallusto, W. Luini, D. Zhou, L. Piemonti, P. Allavena, J. Van Damme, S. Valitutti, A. Lanzavecchia, and A. Mantovani. 1995. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. J. Immunol. 155: 3292–3295.

    Google Scholar 

  56. Xu, L. L., M. K. Warren, W. L. Rose, W. Gong, and J. M. Wang. 1996. Human recombinant monocyte chemotactic protein and other C-C chemokines bind and induce directional migration of dendritic cells in vitro. J. Leuk. Biol. 60 (3): 365–371.

    CAS  Google Scholar 

  57. Grewal, I. S., B. J. Rutledge, J. A. Fiorillo, L. Gu, R. P. Gladue, R. A. Flavell, and B. J. Rollins. 1997. Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J. Immunol. 159: 401–408.

    PubMed  CAS  Google Scholar 

  58. Olin, S., G. LaRosa, J. J. Campbell, H. Smith-Heath, N. Kassam, X. Shi, L. Zeng, E. C. Buthcher, and C. R. Mackay. 1996. Expression of monocyte chemoattractant protein-1 and interleukin-8 receptors on subsets of T cells: correlation with transendothelial chemotactic potential. Eur. J. Immunol. 26: 640–647.

    Article  Google Scholar 

  59. Loetscher, P., M. Seitz, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1996. Activation of NK cells by CC chemokines: chemotaxis, Ca2+ mobilization, and enzyme release. J. Immunol. 156: 322–327.

    Google Scholar 

  60. Tangirala, R. K., K. Murao, and O. Quehenberger. 1997. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines. J. Biol. Chem. 272: 8050–8056.

    Article  PubMed  CAS  Google Scholar 

  61. Rollins, B. J., A. Walz, and M. Baggiolini. 1991. Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 78: 1112–1116.

    Google Scholar 

  62. Rollins, B. J., and M. E. Sunday. 1991. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells. Mol. Cell. Biol. 11: 3125–3131.

    Google Scholar 

  63. Kaufman, R. J., P. Murtha, and M. Davies. 1987. Translational efficiency of polycistronic mRNAs and their utilization to express heterologous genes in mammalian cells. EMBO J. 6: 187–193.

    PubMed  CAS  Google Scholar 

  64. Walter, S., B. Bottazzi, D. Govoni, F. Colotta, and A. Mantovani. 1991. Macrophage infiltration and growth of sarcoma clones expressing different amounts of monocyte chemotactic protein/JE. Int. J. Cancer 49: 431–435.

    Article  PubMed  CAS  Google Scholar 

  65. Bottazzi, B., S. Walter, D. Govoni, F. Colotta, and A. Mantovani. 1992. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma. J. Immunol. 148: 1280–1285.

    PubMed  CAS  Google Scholar 

  66. Yamashira, S., M. Takeya, T. Nishi, J. Kuratsu, T. Yoshimura, Y. Ushio, and K. Takahashi. 1994. Tumor derived monocyte chemoattractant protein-1 induces intratumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors. Am. J. Pathol. 145: 856–867.

    Google Scholar 

  67. Huang, S., R. K. Singh, K. Xie, M. Gutman, K. K. Berry, C. D. Bucana, I. J. Fidler, and M. Bar-Eli. 1994. Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells. Cancer Immunol. Immunother. 39: 231–238.

    Article  PubMed  CAS  Google Scholar 

  68. Negus, R. P., G. W. Stamp, J. Hadley, and F. R. Balkwill. 1997. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of C-C chemokines. Am. J. Pathol. 150: 1723–1734.

    PubMed  CAS  Google Scholar 

  69. Zhang, L., A. Khayat, H. Cheng, and D. T. Graves. 1997. The pattern of monocyte recruitment in tumors is modulated by MCP-1 expression and influences the rate of tumor growth. Lab. Invest. 76: 579–590.

    PubMed  CAS  Google Scholar 

  70. Manome, Y., P. Y. Wen, A. Hershowitz, T. Tanaka, B. J. Rollins, D. W. Kufe, and H. A. Fine. 1995. Monocyte chemoattractant protein-1 (MCP-1) gene transduction: an effective tumor vaccine strategy for non-intracranial tumors. Cancer Immunol. Immunother. 41: 227–235.

    Google Scholar 

  71. Singh, R. K., K. Berry, K. Matsushima, K. Yasumoto, and I. J. Fidler. 1993. Synergism between human monocyte chemotactic and activating factor and bacterial products for activation of tumoricidal properties in murine macrophages. J. Immunol. 151: 2786–2793.

    PubMed  CAS  Google Scholar 

  72. Nishioka, Y., S. Yano, F. Fujiki, N. Mukaida, K. Matsushima, T. Tsuruo, and S. Sone. 1997. Combined therapy of multidrug-resistant human lung cancer with anti-P-glycoprotein antibody and monocyte chemoattractant protein-1 gene transduction: the possibility of immunological overcoming of multidrug resistance. Int. J. Cancer 71: 170–177.

    Article  PubMed  CAS  Google Scholar 

  73. Brooks, W. H., M. G. Netsky, D. E. Normansell, and D. A. Horwitz. 1972. Depressed cell-mediated immunity in patients with primary intracranial tumors: characterization of a humoral immunosuppressive factor. J. Exp. Med. 136: 1631–1647.

    Article  PubMed  CAS  Google Scholar 

  74. Kuratsu, J., K. Yoshizato, T. Yoshimura, E. J. Leonard, H. Takeshima, and Y. Ushio. 1993. Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. J. Natl. Cancer Inst. 85: 1836–1839.

    Article  PubMed  CAS  Google Scholar 

  75. Boetcher, D. A., and E. J. Leonard. 1974. Abnormal monocyte chemotactic response in cancer patients. J. Natl. Cancer Inst. 52: 1091–1099.

    PubMed  CAS  Google Scholar 

  76. Snyderman, R., M. C. Pike, L. Meadows, G. Hemstreet, and S. Wells. 1975. Depression of monocyte chemotaxis by neoplasia. Clin. Res. 34: 297A.

    Google Scholar 

  77. Normann, S. J., and E. Sorkin. 1977. Inhibition of macrophage chemotaxis by neoplastic and other rapidly proliferating cells in vitro. Cancer Res. 37: 705–711.

    CAS  Google Scholar 

  78. Goldsmith, H. S., A. G. Levin, and C. M. Southam. 1965. A study of cellular responses in cancer patients by qualitative and quantitative Rebuck tests. Surg. Forum 16: 102–104.

    PubMed  CAS  Google Scholar 

  79. Dizon, Q. S., and C. M. Southam. 1963. Abnormal cellular response to skin abrasion in cancer patients. Cancer 16: 1288–1292.

    Article  PubMed  CAS  Google Scholar 

  80. Snyderman, R., M. C. Pike, B. L. Blaylock, and P. Weinstein. 1976. Effects of neoplasms on inflammation: depression of macrophage accumulation after tumor implantation. J. Immunol. 116: 585–589.

    PubMed  CAS  Google Scholar 

  81. North, R. J., D. P. Kirstein, and R. L. Tuttle. 1976. Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J. Exp. Med. 143: 559–573.

    Article  PubMed  CAS  Google Scholar 

  82. Takeshima, H., J. Kuratsu, M. Takeya, T. Yoshimura, and Y. Ushio. 1994. Expression and localization of messenger RNA and protein for monocyte chemoattractant protein-1 in human malignant glioma. J. Neurosurg. 80: 1056–1062.

    Article  PubMed  CAS  Google Scholar 

  83. Furutani, Y., H. Nomura, M. Notake, Y. Oyamada, T. Fukui, M. Yamada, C. G. Larsen, J. J. Oppenheim, and K. Matsushima. 1989. Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF). Biochem. Biophys. Res. Commun. 159: 249–255.

    Article  PubMed  CAS  Google Scholar 

  84. Van Damme, J., B. Decock, J. P. Lenaerts, R. Conings, R. Bertini, A. Montovani, and A. Billau. 1989. Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double-stranded RNA or cytokine. Eur. J. Immunol. 19: 2367–2373.

    Article  PubMed  CAS  Google Scholar 

  85. Negus, R. P., G. W. Stamp, M. G. Relf, F. Burke, S. T. Malik, S. Bernasconi, P. Allavena, S. Sozzani, A. Mantovani, and F. R. Balkwill. 1995. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J. Clin. Invest. 95: 2391–2396.

    Article  PubMed  CAS  Google Scholar 

  86. Sonouchi, K., T. A. Hamilton, C. S. Tannenbaum, R. R. Tubbs, R. Bukowski, and J. H. Finke. 1994. Chemokine gene expression in the murine renal cell carcinoma, RENCA, following treatment in vivo with Interferon-a and Interleukin-2. Am. J. Pathol. 144: 747–755.

    PubMed  CAS  Google Scholar 

  87. Melani, C., S. M. Pupa, A. Stoppacciaro, S. Menard, M. I. Colnaghi, G. Parmiani, and M. P. Colombo. 1995. An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines. Int. J. Cancer 62: 572–578.

    Article  PubMed  CAS  Google Scholar 

  88. Graves, D. T., R. Barnhill, T. Galanopoulos, and H. N. Antoniades. 1992. Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am. J. Pathol. 140: 9–14.

    PubMed  CAS  Google Scholar 

  89. Takeya, M., T. Yoshimura, E. J. Leonard, T. Kato, H. Okabe, and K. Takahashi. 1991. Production of monocyte chemoattractant protein-1 by malignant fibrous histiocytoma: relation to the origin of histiocyte-like cells. Exp. Mol. Pathol. 54: 61–71.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Rollins, B.J., Fine, H.A., Gu, L., Soejima, K., Tseng, S. (1999). Tumor Infiltration by Monocytes and the Antitumor Effects of Monocyte Chemoattractant Protein-1. In: Rollins, B.J. (eds) Chemokines and Cancer. Contemporary Cancer Research. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-701-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-701-7_6

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4757-4760-7

  • Online ISBN: 978-1-59259-701-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics